Martin Fan
Stock Analyst at Wedbush
(4.82)
# 89
Out of 5,118 analysts
16
Total ratings
86.67%
Success rate
76.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBIO Zenas BioPharma | Reiterates: Outperform | $45 | $39.05 | +15.24% | 3 | Dec 22, 2025 | |
| VOR Vor Biopharma | Assumes: Neutral | $9 | $13.72 | -34.40% | 1 | Nov 25, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $6.41 | -68.80% | 1 | Nov 25, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $50 | $50.91 | -1.79% | 4 | Nov 24, 2025 | |
| SANA Sana Biotechnology | Maintains: Outperform | $5 → $6 | $4.12 | +45.63% | 2 | Nov 7, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Outperform | $18 → $23 | $4.43 | +419.19% | 2 | Oct 17, 2025 | |
| RNAC Cartesian Therapeutics | Initiates: Outperform | $38 | $6.43 | +490.98% | 1 | Jul 9, 2025 | |
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $3.01 | +165.78% | 1 | May 28, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Outperform | $40 | $30.90 | +29.45% | 1 | May 15, 2025 |
Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $39.05
Upside: +15.24%
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $13.72
Upside: -34.40%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.41
Upside: -68.80%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $50.91
Upside: -1.79%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5 → $6
Current: $4.12
Upside: +45.63%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $4.43
Upside: +419.19%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $6.43
Upside: +490.98%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $3.01
Upside: +165.78%
Oruka Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $40
Current: $30.90
Upside: +29.45%